Mode
Home
Conditions Medications Drug Pipeline Weekly Digests
Text Size
Log in / Sign up
Home › Conditions › Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

2 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Phase II trial of oral pamiparib in recurrent ovarian cancer after prior PARPi exposure
Oncology Phase II
Phase II trial of oral pamiparib in recurrent ovarian cancer after prior PARPi exposure Pamiparib alone offers limited hope for ovarian cancer patients who have already tried other drugs
This prospective Phase II clinical trial enrolled 15 patients with recurrent ovarian cancer after prior PARPi exposure.
New data shows taking pamiparib by itself works for only a small number of women with recurrent ovarian cancer after other treatments failed
May 1, 2026
Phase 1/2 Study of Dual-Target CAR-NK Cells in Recurrent Ovarian Cancer
OB/GYN & Women's Health Phase II
Phase 1/2 Study of Dual-Target CAR-NK Cells in Recurrent Ovarian Cancer Could New Cell Therapy Change the Game for Women with Recurrent Ovarian Cancer?
This Phase 1/2 trial assesses the safety and preliminary efficacy of dual-target CAR-NK cells in recurrent ovarian cancer, focusing on dose-…
Women with recurrent ovarian cancer may find new hope in a trial testing dual-target CAR-NK cells designed to attack tumors that resist stan…
CT.gov Mar 27, 2026